1. Home
  2. CGEM vs BH Comparison

CGEM vs BH Comparison

Compare CGEM & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • BH
  • Stock Information
  • Founded
  • CGEM 2016
  • BH 1934
  • Country
  • CGEM United States
  • BH United States
  • Employees
  • CGEM N/A
  • BH N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • BH Restaurants
  • Sector
  • CGEM Health Care
  • BH Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • BH Nasdaq
  • Market Cap
  • CGEM 530.0M
  • BH 904.4M
  • IPO Year
  • CGEM 2021
  • BH N/A
  • Fundamental
  • Price
  • CGEM $7.66
  • BH $297.21
  • Analyst Decision
  • CGEM Strong Buy
  • BH
  • Analyst Count
  • CGEM 5
  • BH 0
  • Target Price
  • CGEM $30.00
  • BH N/A
  • AVG Volume (30 Days)
  • CGEM 354.7K
  • BH 20.6K
  • Earning Date
  • CGEM 08-07-2025
  • BH 08-08-2025
  • Dividend Yield
  • CGEM N/A
  • BH N/A
  • EPS Growth
  • CGEM N/A
  • BH N/A
  • EPS
  • CGEM N/A
  • BH N/A
  • Revenue
  • CGEM N/A
  • BH $367,698,000.00
  • Revenue This Year
  • CGEM N/A
  • BH N/A
  • Revenue Next Year
  • CGEM N/A
  • BH N/A
  • P/E Ratio
  • CGEM N/A
  • BH N/A
  • Revenue Growth
  • CGEM N/A
  • BH 0.85
  • 52 Week Low
  • CGEM $6.85
  • BH $159.69
  • 52 Week High
  • CGEM $21.01
  • BH $298.49
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 40.12
  • BH 61.69
  • Support Level
  • CGEM $7.29
  • BH $282.42
  • Resistance Level
  • CGEM $8.05
  • BH $295.81
  • Average True Range (ATR)
  • CGEM 0.42
  • BH 8.33
  • MACD
  • CGEM -0.07
  • BH -0.83
  • Stochastic Oscillator
  • CGEM 17.48
  • BH 65.19

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.

Share on Social Networks: